Download Presentation: Antibody structure-guided optimization: OptimAbs


Developing therapeutic monoclonal antibodies and ADC's is a key focus of the pharmaceutical industry's R&D. The European Antibody Congress 2012 bought together senior level executives and opinion leaders from around the globe to further their knowledge and engage in discussion on a variety of topics relating to mAbs, ADC's and bispecifics. Attendees at this highly successful event were fortunate enough to hear this exciting presentation delivered by Alain Beck, Head of Physico-Chemistry Department, Centre d'Immunologie Pierre Fabre; Associate Editor, mAbs, ‘Antibody structure-guided optimization: OptimAbs'.


This presentation focuses on:

· Antibody lead optimization based on emergent mass spectrometry methods

· Improving antibody developability by identification of Critical Quality Attributes

· Gaining insights in structure-function relationships by analyzing antibody/ antigen complexes


Download this presentation here.


Are you interested in learning more and engaging in discussion on mAbs, ADC's, bispecifics and antibody biosimilars? Do you want to hear the most recent updates on mAbs/ADC's at the clinical stage? Do you want to network with senior executives and opinion leaders from truly international antibody pioneers? Take a look at the European Antibody Congress 2013. 

Alain Beck will once again be returning to the European Antibody Congress as a speaker in 2013.

Comments 1

Leave a Reply

Your email address will not be published. Required fields are marked *